Biopharma Development & Production 2019
Download Brochure Request

Register your interest


Register your interest


Biopharma Development & Production 2019

14 – 16 May 2019, China

Book Now Download Brochure



With 350+ participants representing the core of China’s market, the Biopharma Development & Production Week is back to spur industry learning, showcase innovation and enable business contacts. With 3 co located conferences, 70+ speakers and over 60 technical and commercial sessions, this is without doubt the only forum with demonstrated value add for participants.

Against the bedrock of emerging and disruptive technologies, new generation facilities and continuous process improvement, participants will get quality practical information that enables them to develop advance capabilities in developing and manufacturing cell lines, biosimilars, biobetters, antibodies, vaccines and novel biologics.

2018 Attendees List

View list >>

Choose your language

Part of

Biopharma Development & Production >>

Co-Located Events

Biosimilars Asia >>
Cell Line Development and Engineering >>
Biomanufacturing >>


Packages Price
2 Day Conference - International Companies, Global HQ Located Outside ChinaUS $1895US $1695Early BirdEarly Bird
2 Day Conference - Local China CompaniesUS $977US $827Early BirdEarly Bird
Group of 2 or more delegates - International Companies, Global HQ Located Outside ChinaUS $1495Early Bird
Group of 2 or more delegates - Local China CompaniesUS $752Early Bird
Group of 4 or more delegates - International Companies, Global HQ Located Outside ChinaUS $1295Early Bird
Group of 4 or more delegates - Local China CompaniesUS $676Early Bird
Extras Price
Pre Conference Workshop - International Companies, Global HQ Located Outside China US $300
Pre Conference Workshop - Local China Companies US $150


  • Multiple Bookings Discount pricing is applicable to groups of 2 or more delegates from the same organisation registering for the same event, at the same time.
  • Fee stated is the discounted price PER DELEGATE. Only one discount applies; either the early bird rate OR group rate.
  • All fees stated include luncheons, refreshments and complete set of documentation. It does not include the cost of accommodation and travel.
  • All delegates from Singapore-based companies are required to pay an additional 7% GST (SINGAPORE EVENTS ONLY)


Partnership and Profile Building Opportunities are Now Available!
Contact us today to find out how you can position your company as a market leader at this event, and to explore the range of branding and marketing opportunities available.

View Sponsors and Exhibitors profile >>

VIP Programme

Become a VIP!
IBC Asia’s VIP Programme is an invitation only based network of the absolute top decision makers across specific industries. Our VIPs get an exclusively designed and tailored programme that enables them to network, indulge and enjoy, whilst experiencing a premium service for the duration of this event.

Dedicated to helping you find the most effective way of engaging with professionals and industry solution providers at our event, and scheduled alongside the main event line-up, it gives you an opportunity to glean benefits from the conference as well, and ensures that you get the most of your time on site with us.

Benefits of becoming a VIP:

  • 1-2-1 Meeting Service (Pre-scheduling meetings with your peers, speakers and other participants you may want to meet)
  • Closed Door Think Tank (An invitation-only forum headlined by an exclusive keynote address)
  • The VIP Lounge
  • Opening Ceremony (Access priority seats and be the first to engage with key speakers and other top decision makers)
  • Your Interview, Promoted Exclusively

A personalized VIP agenda will be sent to you via email upon receiving the confirmation of your registration.

To find out more, please contact:
Angeline Tan, VIP Relations Manager
Phone: +65 6508 2874

Download VIP Programme brochure »


Dr. Ming Wang

President and Chief Executive Officer, Phanes Biopharmaceuticals, China

Xu Wei

Vice President, Manufacturing, Innovent Biologics, China

Xiao Zhi Hua

Chief Executive Officer, OPM Biosciences, China

Wang Honglou

CIO, livzon Pharmaceutical Group, China

Jerry Yang

SVP, Process & Product Development, Hangzhou JUST Biotherapeutics Co., Ltd., China

Jerry Clifford

Chief Operating Officer, Valitacell, Ireland

George Hutchinson

Head of Global Distribution, Solentim, UK

Sunny Zhou

Professor, Department of Chemistry and Chemical Biology Faculty Fellow, Barnett Institute of Chemical and Biological Analysis Northeastern University, Boston, Massachusetts

Dr. John Yan

Applications Scientist, ProZyme

Fai Poon Hung

President, Quacell Biotech, China

Prof. David James

University of Sheffield

Ng Say Kong

Staff Scientist, Animal Cell Technology 2, Bioprocessing Technology Institute, A*STAR

Shaoqing Yang

Vice President, Zhejiang Doer Biologics Co.

Dr. Jinyou Zhang

Senior Vice President/Head, Bio Development and Manufacturing, BeiGene Co. Ltd., China

David Sadler

President & CEO, Kunshan Zotek Kinglai Co. Ltd. U.K.

Joycelyn Kwek

Former Director, Quality Assurance, Amgen Singapore

Hui Cai

Head of QC Laboratory 2 & Head of Microbial Control Team, WuXi Biologics, China

Dr. Dennis Yu Xia

Vice President of Manufacturing and Quality, Akeso Bio, China

Dr. John Zeng

Executive Vice President, Bioprocess Development & Pilot Plant Manufacturing, Shanghai Zerun Biotech Co Ltd, China

Noel Rob

Business Development Manager, Pall Life Sciences, UK

Dr. Scott Liu

President and CEO, Shanghai Henlius Biotech Inc., China

Jiang Junjun

Assistant Director, WuXi Biologics, China

Dr. Jacqueline Ming Liu

Vice President, TOT Biopharma, China

Dr Qiwei Wu

Ph.D, Vice President of Process Development and Manufacturing, Livzon Mabpharma

Dr Amy Hong Que

Vice President - Quality, Innovent Biologics

Prof. Dr. Florian Turk

Head Global Payor Marketing, Sales and Relations, Sandoz Biopharmaceuticals Sandoz International GmbH, Germany

Pearl Fong

Associate Vice President, Division of Project Development, Mycenax Biotech Inc., Taiwan

Bryan Kim

Vice President of Business Development, Samsung Bioepis, Korea

Dr. Xin Zhang

Vice President of Global Clinical Operations and Affairs, Shanghai Henlius Biotech, Inc., China

MinSeob Lee

Team Leader of R&D CMC/PM, Celltrion R&D, Korea

Dr. Alvin Luk

Senior Vice President and Chief Medical Officer, Shanghai Henlius Biotech, Inc., China

Dr Jun Yuan

R&D Director, Quacell Biotechnology Co. Ltd, China

Dong Huifang

Director of Cell Line Development, WuXi Biologics, China

Eric Chang

Head of Cell Line Development, JHL Biotech, Taiwan

Sam Zhang

Senior Principal Scientist/Group Leader, Cell Line Development, Bioprocess R&D, Pfizer Inc, USA

Sai Ling Liu

Product Development Expert, Surfer Biotech, China

Eric Liu

China Biosimilars Regulation Publishing Manager, Pfizer, China

Zheru Zhang

President, I-Mab Biopharma, China

Zack Zheng

Ph.D. VP of Process Development (Wuhan), JHL BioTech, China

Masayoshi Nagaya

Sr. Global Technology Manager, JSR Life Sciences

Dr. Frank Ye

SVP of Manufacturing and Quality, Hangzhou Just Biotherapeutics Co., Ltd., China

John Dubczak

Director of Operations, Charles River Laboratories, U.S.

Iris Desiree Sioson

Reliability Manager, APAC, Envirotainer, Singapore

Swee Nguan Lim

Director of Asia Pacific Sales, Finesse, part of Thermo Fisher Scientific, Singapore

Nicolas-Julian Hilbold

DSP Innovation Specialist, Merck KGaA (sponsored by Novasep)

Aurore Lahille

Head of EMEA E2E Process Development, Merck, France

Yun Kang

Vice President of Manufacturing, Generon Beijing, China

Andrew Huntley

Senior Managing Director, BDA Partners, UK

Keith Breinlinger

Chief Technology Officer, Berkeley Lights, USA

Dr Jun Liu

Vice President, TOT Biopharma, China

Julie Wei

Director, JUST Biotherapeutics, China

Zhiwei Pan

Senior Director of Process Development, Livzon Mabpharm, China

Wang Tong Ying

Chief Technical Officer, Hangzhou Jiuyuan Gene Engineering, China

Zhou Hui

Chief Executive Officer, Glycogene Biotherapeutics, China

Johnson David M

Senior Global Product Manager, Continuous Purification, Pall Life Sciences, U.K.

Eun Young Yang

Executive Director, Head of CDO Business Development Team, Samsung BioLogics

Dr. Jiali Luo

General Manager of Boehringer Ingelheim Biopharmaceuticals China

Dr. Ryan Karcher

Senior R&D Scientist & Team Lead, Merck, USA

Henry Zhang

APAC Technical Application Representative – Cell Nutrition, Kerry Inc., China

Dr. Manfred Weiler

Senior Vice President, Medical & Scientific Strategy, Syneos Health, UK

Dr. Sven Bahrke

Senior Director Cooperations, Glycotope GmBH

Yunfen He

Senior Director, OPM Biosciences

Zhigui Zhou

Director, OPM Biosciences

Lihou Dong

Senior Director, United-Power Pharma

when & where

14 - 16 May 2019


Still have a question?

Speaking Opportunities
Win Min
+65-6508 2873

Sponsorship Opportunities
Yvonne Leong
+65 6508 2489

Media & Association Partnership Opportunities
June Tan
+65 6508 2465


IBC Asia is Singapore's leading event organiser. We conceive, develop and promote our own B2B industry conferences and corporate training courses, and offer tailored managed event solutions.

Find out more